Product Recalls in Nevada

Product recalls affecting Nevada — including food, drugs, consumer products, medical devices, and vehicles distributed to Nevada. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,678 recalls have been distributed to Nevada in the last 12 months.

50,223 total recalls
2,678 in last 12 months

Showing 1050110520 of 13,472 recalls

DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Azithromycin Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zolpidem Tartrate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Amlodipine Besylate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2015· Alvogen, Inc

Recalled Item: NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES Recalled by Alvogen, Inc...

The Issue: Failed Dissolution Specification; 6 month time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2015· Akorn, Inc.

Recalled Item: IC-GREEN (indocyanine green for injection Recalled by Akorn, Inc. Due to...

The Issue: Subpotent Drug: Low out-of-specification potency result of the drug product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 18, 2015· Valeant Pharmaceuticals North America LLC

Recalled Item: Chlordiazepoxide HCl/Clidinium Bromide capsules Recalled by Valeant...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 18, 2015· Valeant Pharmaceuticals North America LLC

Recalled Item: Librax (5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide) capsules...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 17, 2015· Valeant Pharmaceuticals North America LLC

Recalled Item: Nifedipine Extended-Release Tablets Recalled by Valeant Pharmaceuticals...

The Issue: Failed Dissolution Specifications: High out of specification dissolution...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 16, 2015· Tarmac Products, Inc.

Recalled Item: Well at Walgreens Regular Strength Antacid Liquid Recalled by Tarmac...

The Issue: Products failed the Antimicrobial Effectiveness Test.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund